Showing results (151-160 of 1,275) with videos related to

Sort By:
Pageof 128
PET Clinics|April 29, 2025
Applications of Fibroblast Activation Protein Inhibitor-PET in Interventional OncologyYuriko Mori, Emil Novruzov, Frederik L Giesel, et al.
Seminars in Radiation Oncology|September 4, 2017
Thoracic Radiation Normal Tissue InjuryCharles B Simone
PET Clinics|June 18, 2022
Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET TracersDivya Yadav, Rakesh Kumar, Ankita Phulia, et al.
Clinical Nuclear Medicine|June 12, 2004
Iatrogenic artifacts on whole-body F-18 FDG PET imagingPeeyush Bhargava, Hongming Zhuang, Rakesh Kumar, et al.
Expert Opinion on Medical Diagnostics|March 16, 2013
Imaging for the diagnosis of thyroid cancerMuammer Urhan, Murat Velioglu, Joshua Rosenbaum, et al.
Clinical Nuclear Medicine|August 22, 2007
Intercostal muscle contraction or rib bone marrow activity?: Look for ancillary cluesSandip Basu, Saad Alzeair, Geming Li, et al.
Japanese Journal of Radiology|May 4, 2010
18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in a patient with human immunodeficiency virus-associated Castleman's disease and Kaposi sarcoma, disorders associated with human herpes virus 8 infectionFrancesco Bertagna, Giorgio Biasiotto, Rosita Rodella, et al.
PET Clinics|July 18, 2014
Differential background clearance of fluorodeoxyglucose activity in normal tissues and its clinical significanceGang Cheng, Abass Alavi, Nam Ju Lee, et al.
Hellenic Journal of Nuclear Medicine|October 19, 2013
An evaluation of the predictive value of mid-treatment 18F-FDG-PET/CT scans in pediatric lymphomas and undefined criteria of abnormality in quantitative analysisHongyun J Zhu, Raghuveer Halkar, Abass Alavi, et al.
Molecular Imaging and Biology|November 15, 2007
Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology?Sandip Basu, Ayse Mavi, Tevfik Cermik, et al.
Pageof 128